Blog | NB Medical
 
NO
PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE

Sleepless nights, restless hearts: spotting the OSA-AF connection

Sleepless nights, restless hearts: spotting the OSA-AF connection image
Dr Simon Curtis
27th November 2024

Our patients are our best teachers. I remember one, let’s call him Mike, who first taught me the link between atrial fibrillation and obstructive sleep apnoea (OSA). He was a large guy, always smiley and...

Rescue therapy in T2 diabetes - Clara's story

Rescue therapy in T2 diabetes - Clara's story image
Dr Zoe Norris
19th November 2024

Clara was 84yrs old and lived in the residential home that was within walking distance of the surgery. Most days there would be one or two visits in the home, that was largely filled with our patients....

Menopause management – are new NICE guidelines 2 steps forward but one step back? 

Menopause management – are new NICE guidelines 2 steps forward but one step back?  image
Dr Siobhan Becker
13th November 2024

Last year NICE released a draft of its update to its menopause guidelines and they were greeted with howls of despair from many of us who spend every day talking and consulting with women in primary care...

Identifying the sick child- will the NHSE PEWS score help us in primary care?

Identifying the sick child- will the NHSE PEWS score help us in primary care? image
Dr Laura Darby
5th November 2024

How do we identify a sick child?  Wouldn’t it be great if there was a handy scoring system that could accurately predict those at risk of serious illness who may need admission? Or just as importantly...

Remission of type 2 diabetes - Is it worth the effort?

Remission of type 2 diabetes - Is it worth the effort? image
Dr Rob Walker
29th October 2024

When I started as a GP just shy of 20 years ago, type 2 diabetes (T2DM) was viewed as a progressive disease that, at best, could be managed, but not reversed. Management was based around the relatively...

FINEARTS for fine hearts

FINEARTS for fine hearts image
Dr Nick Jones
23rd October 2024

Mineralocorticoid receptor antagonists (MRA), such as spironolactone, have been recommended as one of the key treatments for people with heart failure with reduced ejection fraction (HFrEF) for more than...